Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2018

Equity [Abstract]

Schedule of Nonvested Restricted Stock Units Activity

The following table summarizes the activity related to restricted stock units awarded to employees of our Manager and its affiliates for the three months ended March 31, 2018.

	Three Months Ended March 31,
	2018
	Restricted Stock Units		Weighted Average Grant Date Fair Value (1)
Unvested at the beginning of the period	19,827		$	14.35
Shares granted during the period	7,055		15.37
Shares vested during the period	(7,697	)	14.75
Unvested at the end of the period	19,185		$	14.56

(1) The grant date fair value of restricted stock awards is based on the closing market price of our common stock at the grant date.

Schedule of accumulated other comprehensive income

The tables exclude gains and losses on MBS and GSE CRTs that are accounted for under the fair value option.

	Three Months Ended March 31, 2018
$ in thousands	Equity method investments		Available-for-sale securities		Derivatives and hedging		Total
Total other comprehensive income/(loss)
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net	—		(132,317	)	—		(132,317	)
Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net	—		9,237		—		9,237
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense	—		—		(6,539	)	(6,539	)
Currency translation adjustments on investment in unconsolidated venture	312		—		—		312
Total other comprehensive income/(loss)	312		(123,080	)	(6,539	)	(129,307	)
AOCI balance at beginning of period	947		136,188		123,894		261,029
Total other comprehensive income/(loss)	312		(123,080	)	(6,539	)	(129,307	)
Other comprehensive income/(loss) attributable to non-controlling interest	(4	)	1,552		82		1,630
AOCI balance at end of period	1,255		14,660		117,437		133,352

	Three Months Ended March 31, 2017
$ in thousands	Equity method investments		Available-for-sale securities		Derivatives and hedging		Total
Total other comprehensive income/(loss)
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net	—		16,289		—		16,289
Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net	—		850		—		850
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense	—		—		(6,298	)	(6,298	)
Currency translation adjustments on investment in unconsolidated venture	(615	)	—		—		(615	)
Total other comprehensive income/(loss)	(615	)	17,139		(6,298	)	10,226
AOCI balance at beginning of period	95		144,458		149,115		293,668
Total other comprehensive income/(loss)	(615	)	17,139		(6,298	)	10,226
Other comprehensive income/(loss) attributable to non-controlling interest	8		(216	)	79		(129	)
AOCI balance at end of period	(512	)	161,381		142,896		303,765